Drug Cos. Sold Contaminated Blood Pressure Meds, Suit Says

Law360 (October 11, 2018, 8:42 PM EDT) -- A proposed class of consumers hit Solco Healthcare U.S. LLC and Prinston Pharmaceutical Inc. with a lawsuit Thursday in New Jersey federal court claiming the companies violated consumer fraud laws by selling a drug used to treat high blood pressure and heart failure that was contaminated with a potentially cancer-causing substance.

Richard O’Neill, a Kansas resident who has been taking the generic prescription drug valsartan for more than a year, contends in the proposed class action that the companies distributed the drug even though they knew, or should have known, it was contaminated with the liver-damaging impurity N-Nitrosodimethylamine, or NDMA....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!